vs
STANDARD BIOTOOLS INC.（LAB）与OHIO VALLEY BANC CORP（OVBC）财务数据对比。点击上方公司名可切换其他公司
STANDARD BIOTOOLS INC.的季度营收约是OHIO VALLEY BANC CORP的1.2倍（$19.6M vs $16.2M），OHIO VALLEY BANC CORP净利率更高（24.4% vs -177.4%，领先201.8%），OHIO VALLEY BANC CORP同比增速更快（-4.6% vs -11.5%），OHIO VALLEY BANC CORP自由现金流更多（$17.0M vs $-23.1M），过去两年OHIO VALLEY BANC CORP的营收复合增速更高（4.3% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
俄亥俄谷银行公司旗下的亚利桑那 Valley 国民银行总部位于亚利桑那州凤凰城，成立于1900年，1992年被第一银行收购。该银行是20世纪亚利桑那州顶尖的金融机构之一，在被收购时是该州最后一家大型独立银行。
LAB vs OVBC — 直观对比
营收规模更大
LAB
是对方的1.2倍
$16.2M
营收增速更快
OVBC
高出6.8%
-11.5%
净利率更高
OVBC
高出201.8%
-177.4%
自由现金流更多
OVBC
多$40.1M
$-23.1M
两年增速更快
OVBC
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $16.2M |
| 净利润 | $-34.7M | $4.0M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 30.7% |
| 净利率 | -177.4% | 24.4% |
| 营收同比 | -11.5% | -4.6% |
| 净利润同比 | -28.8% | 57.3% |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABOVBC
| Q4 25 | — | $16.2M | ||
| Q3 25 | $19.6M | $16.3M | ||
| Q2 25 | $21.8M | $17.4M | ||
| Q1 25 | $40.8M | $16.8M | ||
| Q4 24 | — | $17.0M | ||
| Q3 24 | $22.1M | $15.4M | ||
| Q2 24 | $22.5M | $14.7M | ||
| Q1 24 | $45.5M | $14.9M |
净利润LABOVBC
| Q4 25 | — | $4.0M | ||
| Q3 25 | $-34.7M | $3.0M | ||
| Q2 25 | $-33.5M | $4.2M | ||
| Q1 25 | $-26.0M | $4.4M | ||
| Q4 24 | — | $2.5M | ||
| Q3 24 | $-26.9M | $2.7M | ||
| Q2 24 | $-45.7M | $3.0M | ||
| Q1 24 | $-32.2M | $2.8M |
毛利率LABOVBC
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABOVBC
| Q4 25 | — | 30.7% | ||
| Q3 25 | -168.5% | 22.9% | ||
| Q2 25 | -118.1% | 29.8% | ||
| Q1 25 | -80.8% | 33.1% | ||
| Q4 24 | — | 18.1% | ||
| Q3 24 | -120.9% | 21.3% | ||
| Q2 24 | -134.5% | 24.7% | ||
| Q1 24 | -132.2% | 22.8% |
净利率LABOVBC
| Q4 25 | — | 24.4% | ||
| Q3 25 | -177.4% | 18.5% | ||
| Q2 25 | -153.7% | 24.2% | ||
| Q1 25 | -63.8% | 26.2% | ||
| Q4 24 | — | 14.8% | ||
| Q3 24 | -122.0% | 17.6% | ||
| Q2 24 | -203.3% | 20.3% | ||
| Q1 24 | -70.6% | 18.8% |
每股收益（稀释后）LABOVBC
| Q4 25 | — | — | ||
| Q3 25 | $-0.09 | — | ||
| Q2 25 | $-0.09 | — | ||
| Q1 25 | $-0.07 | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-0.07 | — | ||
| Q2 24 | $-0.12 | — | ||
| Q1 24 | $-0.27 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $45.9M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $399.7M | $170.3M |
| 总资产 | $539.6M | $1.6B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LABOVBC
| Q4 25 | — | $45.9M | ||
| Q3 25 | $129.4M | $89.3M | ||
| Q2 25 | $158.6M | $54.6M | ||
| Q1 25 | $150.9M | $120.6M | ||
| Q4 24 | — | $83.1M | ||
| Q3 24 | $210.6M | $82.2M | ||
| Q2 24 | $269.8M | $107.7M | ||
| Q1 24 | $287.1M | $129.1M |
总债务LABOVBC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $55.2M | — | ||
| Q2 24 | $55.1M | — | ||
| Q1 24 | $55.0M | — |
股东权益LABOVBC
| Q4 25 | — | $170.3M | ||
| Q3 25 | $399.7M | $164.4M | ||
| Q2 25 | $424.5M | $160.8M | ||
| Q1 25 | $454.6M | $155.7M | ||
| Q4 24 | — | $150.3M | ||
| Q3 24 | $489.3M | $152.2M | ||
| Q2 24 | $510.3M | $145.8M | ||
| Q1 24 | $577.3M | $145.8M |
总资产LABOVBC
| Q4 25 | — | $1.6B | ||
| Q3 25 | $539.6M | $1.6B | ||
| Q2 25 | $557.0M | $1.5B | ||
| Q1 25 | $579.6M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | $681.5M | $1.5B | ||
| Q2 24 | $708.7M | $1.4B | ||
| Q1 24 | $777.7M | $1.4B |
负债/权益比LABOVBC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.11× | — | ||
| Q2 24 | 0.11× | — | ||
| Q1 24 | 0.10× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $18.1M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $17.0M |
| 自由现金流率自由现金流/营收 | -118.1% | 105.2% |
| 资本支出强度资本支出/营收 | 4.5% | 6.4% |
| 现金转化率经营现金流/净利润 | — | 4.57× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $26.5M |
8季度趋势，按日历期对齐
经营现金流LABOVBC
| Q4 25 | — | $18.1M | ||
| Q3 25 | $-22.2M | $5.3M | ||
| Q2 25 | $-20.7M | $4.5M | ||
| Q1 25 | $-30.3M | $496.0K | ||
| Q4 24 | — | $13.1M | ||
| Q3 24 | $-27.9M | $5.6M | ||
| Q2 24 | $-39.0M | $4.2M | ||
| Q1 24 | $-62.5M | $928.0K |
自由现金流LABOVBC
| Q4 25 | — | $17.0M | ||
| Q3 25 | $-23.1M | $5.0M | ||
| Q2 25 | $-22.6M | $4.4M | ||
| Q1 25 | $-35.3M | $138.0K | ||
| Q4 24 | — | $11.7M | ||
| Q3 24 | $-30.1M | $5.4M | ||
| Q2 24 | $-41.0M | $3.9M | ||
| Q1 24 | $-63.3M | $234.0K |
自由现金流率LABOVBC
| Q4 25 | — | 105.2% | ||
| Q3 25 | -118.1% | 30.4% | ||
| Q2 25 | -103.6% | 25.1% | ||
| Q1 25 | -86.6% | 0.8% | ||
| Q4 24 | — | 68.7% | ||
| Q3 24 | -136.4% | 35.1% | ||
| Q2 24 | -182.2% | 26.3% | ||
| Q1 24 | -138.9% | 1.6% |
资本支出强度LABOVBC
| Q4 25 | — | 6.4% | ||
| Q3 25 | 4.5% | 2.1% | ||
| Q2 25 | 8.7% | 0.6% | ||
| Q1 25 | 12.4% | 2.1% | ||
| Q4 24 | — | 8.4% | ||
| Q3 24 | 10.2% | 1.2% | ||
| Q2 24 | 8.6% | 2.2% | ||
| Q1 24 | 1.7% | 4.7% |
现金转化率LABOVBC
| Q4 25 | — | 4.57× | ||
| Q3 25 | — | 1.75× | ||
| Q2 25 | — | 1.06× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 5.21× | ||
| Q3 24 | — | 2.06× | ||
| Q2 24 | — | 1.41× | ||
| Q1 24 | — | 0.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
OVBC
暂无分部数据
